In Alzheimer’s Disease (AD), for instance, reduced BDNF levels are associated with the accumulation of beta-amyloid plaques and tau tangles (22, 23), while in Parkinson’s disease, BDNF stimulation can promote the dopaminergic neuron survival and differentiation in the substantia nigra (24). This evidence concerns the gene MAPT and Alzheimer disease.